Cervical Cancer Screening in Korea

자궁경부암 세포 조기진단의 현황

  • Park, Moon-Hyang (Department of Pathology, Hanyang University College of Medicine)
  • 박문향 (한양대학교 의과대학 병리학교실)
  • Published : 2003.11.30

Abstract

The incidence of cervical cancer has been gradually decreased since 1990, now it ranks the fourth most common carcinoma among Korean women in 2001. If squamous cell carcinomas in situ are included, the cervical cancer is still the most frequent tumor in Korean women. However, cervical cancer mortality in Korea has been decreased over the last 10 years in large part attributable to the introduction of the Papanicolaou test (Pap. test). The guidelines for the early detection of cervical cancer recommend women aged 30 and more to lake biennial screening with Pap. lest. According to the screening data of National Health Insurance Corporation (NHIC), 4,425 women (0.94%) showed an abnormal Pap among 473,395 cases tested in 2001; dysplasia was in 3,953 (0.84%) women, in situ carcinoma in 357 (0.075%) women, and invasive carcinoma in 115 (0.024%) women. The detection rates of abnormal Pap. were 4.21% in Korean Society for Cytopathology(KSC-2001), 1.37% (ASCUS : 0.26%, AGUS : 0.03%, LSIL : 0.45%, HSIL : 0.55%, Carcinoma 0.09%) in health check-up and 5.41% (ASCUS : 1.89%, AGUS . : 0.69%, LSIL : 1.39%, HSIL : 0.84%, Carcinoma : 0.64%) of patients in out-patient clinic without having history of cervical neoplasia at Hanyang University Hospital in 2002 Low rate of cervical cancer screening (34%) in Korea is mainly due to the lack of information for the Row income people regarding national cancer screening program. More adenuate budget by government and more man-power for precise screening, new guideline and system for management of the cervical cancer patients are required.

References

  1. 오대규. 국가 암관리정책. 국가암조기검진사업을 중심으로, 대한의사협회지 2003;46:668-9
  2. Shin H-R, Ahn Y-O, Bae J-M, et a1. Cancer incidence in Korea. Cancer Research and Treatment 2002;34:405-8 https://doi.org/10.4143/crt.2002.34.6.405
  3. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153-6 https://doi.org/10.1002/ijc.1440
  4. 박상윤, 강선광. 특집/국내 5대 호발암의 조기발견을 위한 검진지침-자궁경부암의 검진 권고안. 대한의사협회지 2002;45:1005-14
  5. Saslou D, Runowicz C, Solomon D. et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52:342-2 https://doi.org/10.3322/canjclin.52.6.342
  6. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society. American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin 2003;53:27-43 https://doi.org/10.3322/canjclin.53.1.27
  7. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. ASCCP-Sponsored Consensus Conference. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-9 https://doi.org/10.1001/jama.287.16.2120
  8. Davey DD, Austin RM, Birdsong G, et ai, ASCCP patient management guidelines: Pap test specimen adequacy and quality indicators. Am J Clin Pathol 2002;118:714-8 https://doi.org/10.1309/6GBF-EGH8-WXDE-ANGX
  9. Wright TC Jr, Cox JT, Massad LS, Carlson J, Twiggs LB, Wilkinson EJ. American Society for Colposcopy and Cervical Pathology. 2001 consensus guidelines for the management of women with cervical intraepithelial neo-plasia. Am J Obstet Gynecol 2003;189:295-304 https://doi.org/10.1067/mob.2003.633
  10. Jones HW. The Bethesda System. Cancer 1996;78(suppl): 1914-18
  11. 홍은경,남종희, 박문향 The Bethesda System 2001 의 최신지견. 대한세포병리학회지 2001;12:1-15
  12. 국민건강보험공단. 2001년도 건강검진 결과분석. 2002
  13. 이원철. 국내 자궁경부암조기검진 현황. 제1회 자궁경부암 지침개발 2001